Hm Payson & CO Mckesson Corp Transaction History

Hm Payson & CO

$5.37 Billion
Q1 2024

A detailed history of Hm Payson & CO transactions in Mckesson Corp stock. As of the latest transaction made, Hm Payson & CO holds 4,775 shares of MCK stock, worth $2.79 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,775

Previous 4,996 4.42%

Holding current value

$2.79 Million

Previous $2.31 Million 10.81%

% of portfolio

0.05%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 20, 2024	SELL	$473.42 - $539.26 $104,625 - $119,176	-221 Reduced 4.42%	4,775 $2.56 Million
Q4 2023 Feb 13, 2024	SELL	$437.42 - $470.64 $284,323 - $305,916	-650 Reduced 11.51%	4,996 $2.31 Million
Q3 2023 Nov 06, 2023	BUY	$402.4 - $446.42 $57,945 - $64,284	144 Added 2.62%	5,646 $2.46 Million
Q2 2023 Jul 17, 2023	BUY	$354.01 - $427.31 $1.44 Million - $1.74 Million	4,062 Added 282.08%	5,502 $2.35 Million
Q4 2022 Feb 06, 2023	BUY	$346.68 - $397.58 $3,813 - $4,373	11 Added 0.77%	1,440 $540,000

Q2 2022 Aug 15, 2022	SELL	$300.57 - $336.42 $2,103 - $2,354	-7 Reduced 0.49%	1,429 $466,000
Q1 2022 May 12, 2022	BUY	$244.61 - $310.48 $1,712 - $2,173	7 Added 0.49%	1,436 $440,000
Q4 2021 Feb 15, 2022	BUY	$198.21 - $248.9 $116,943 - $146,851	590 Added 70.32%	1,429 $355,000
Q4 2020 Mar 10, 2021	SELL	$143.79 - $183.66 $7,764 - $9,917	-54 Reduced 6.05%	839 $146,000
Q2 2020 Aug 13, 2020	SELL	$125.49 - $164.68 $28,611 - $37,547	-228 Reduced 20.34%	893 $137,000
Q1 2020 Jul 01, 2020	BUY	$115.75 - $170.96 $17,709 - $26,156	153 Added 15.81%	1,121 $152,000
Q2 2019 Aug 15, 2019	BUY	$112.47 - $134.93 $108,870 - $130,612	968 New	968 $130,000

Others Institutions Holding MCK

# of Institutions

1,676

Shares Held

109M

Call Options Held

676K

Put Options Held

678K

View Full List

About MCKESSON CORP

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $83.8B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

More about MCK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account